Immunai and Parker Institute to Build Massive Cancer Single-Cell Dataset

Immunai and Parker Institute to Build Massive Cancer Single-Cell Dataset

Immunai, an AI biotech company specializing in mapping the human immune system, and the Parker Institute for Cancer Immunotherapy (PICI), a San Francisco-based nonprofit organization that unites leading immuno-oncology experts from cancer centers across the United States, have announced a new partnership to build “one of the largest” single-cell datasets derived from a single cohort of patients treated with standard-of-care immunotherapy.   Immu…

Immunai & Parker Institute to Build Largest Single-Cell Immune Profiling Patient Database

What You Should Know: –       Immunai, a leading AI biotech company specializing in mapping the human immune system and the Parker Institute for Cancer Immunotherapy (PICI), a collaborative consortium of the world’s leading immuno-oncology experts, announced today that they will build the world’s largest single-cell dataset from patients treated with standard-of-care (SoC) immunotherapy. –       Under the collaboration with PICI, Immunai will pe…